DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm…
| Price | $184.09 |
|---|---|
| Market cap | $11.82B |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
| Exchange | NYSE |
| 52-week range | 101-247.49 |
| Beta | 0.83 |
Explore DVA's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.